These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6927962)

  • 1. Procollagens as markers for the cell of origin of human bone tumors.
    Stern R; Wilczek J; Thorpe WP; Rosenberg SA; Cannon G
    Cancer Res; 1980 Feb; 40(2):325-8. PubMed ID: 6927962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
    Lollini PL; Landuzzi L; Frabetti F; Rossi I; Nicoletti G; Scotlandi K; Serra M; Baldini N; De Giovanni C; Nanni P
    Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Adrenergic receptors in pediatric tumors: uncoupled beta 1-adrenergic receptor in Ewing's sarcoma.
    Whitsett JA; Burdsall J; Workman L; Hollinger B; Neely J
    J Natl Cancer Inst; 1983 Oct; 71(4):779-86. PubMed ID: 6312152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
    Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
    Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
    Zhou Z; Lafleur EA; Koshkina NV; Worth LL; Lester MS; Kleinerman ES
    Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type VIII collagen. Synthesis by normal and malignant cells in culture.
    Sage H; Balian G; Vogel AM; Bornstein P
    Lab Invest; 1984 Feb; 50(2):219-31. PubMed ID: 6694361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors.
    Svoboda M; Thalhammer T; Aust S; Arrich F; Assadian O; Toma CD
    J Surg Oncol; 2007 Jun; 95(7):572-81. PubMed ID: 17230544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix synthesis by undifferentiated childhood tumor cell lines.
    Scarpa S; Modesti A; Triche TJ
    Am J Pathol; 1987 Oct; 129(1):74-85. PubMed ID: 2821816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic in vitro study of the cell kinetics of osteogenic sarcomas and Ewing's sarcomas in children.
    Willnow U
    Arch Geschwulstforsch; 1982; 52(1):9-16. PubMed ID: 6952823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
    Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procollagen synthesis and extracellular matrix deposition in MG-63 osteosarcoma cells.
    Jukkola A; Risteli L; Melkko J; Risteli J
    J Bone Miner Res; 1993 Jun; 8(6):651-7. PubMed ID: 8328306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann JS; Baker L
    Clin Cancer Res; 2002 Mar; 8(3):788-93. PubMed ID: 11895910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric bone tumors: osteosarcoma ewing's sarcoma, and chondrosarcoma associated with multiple hereditary osteochondromatosis.
    Pierz KA; Womer RB; Dormans JP
    J Pediatr Orthop; 2001; 21(3):412-8. PubMed ID: 11371830
    [No Abstract]   [Full Text] [Related]  

  • 15. [Androgen metabolism in malignant and benign bone tumors].
    Kushlinskiĭ NE; Degtiar' VG; Babkina TV; Solov'ev IuN; Aliev MD; Trapeznikov NN
    Biull Eksp Biol Med; 2000 Jan; 129(1):90-2. PubMed ID: 10710639
    [No Abstract]   [Full Text] [Related]  

  • 16. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
    Körner M; Waser B; Reubi JC
    Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clonogenic capacity and proliferative activity of the cells of malignant tumors of the bones].
    Kolesnikova AI; Konopliannikov AG; Bizer VA; Semichastnova LM; Lepekhina LA
    Med Radiol (Mosk); 1986 Dec; 31(12):36-40. PubMed ID: 3540513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas.
    Halmos G; Schally AV; Bernardino AL; Varga JL
    Int J Oncol; 2006 Aug; 29(2):463-9. PubMed ID: 16820890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: implication for cell-based therapy in bone defect reconstruction.
    Beccheroni A; Lucarelli E; Donati D; Sangiorgi L; Capponcelli S; Gorini M; Zambon Bertoja A; Giardino R; Mercuri M; Ferrari S; Bacci G; Picci P
    Oncol Rep; 2003; 10(4):891-6. PubMed ID: 12792741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.